These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 4971230)

  • 21. [Use of hydergine in the psychiatric setting. Clinical study comprising 107 patients of the Hôpital Psychiatrique de Pierrefeu (Var)].
    Boutillier H; Bodilis A; Grégoire F
    Sem Ther; 1967 May; 43(5):300-4. PubMed ID: 4970731
    [No Abstract]   [Full Text] [Related]  

  • 22. Dihydrogenated ergot alkaloids (Hydergine) and cerebrovascular insufficiency.
    Med Lett Drugs Ther; 1970 Mar; 12(6):27-8. PubMed ID: 4994841
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the treatment of osteoporosis: new physiopathological dats. Treatment with calcium and hydergine].
    Eisinger J; Serratrice G; Recordier AM
    Mars Med; 1966; 103(7):588-9. PubMed ID: 4968498
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hydergine therapy of vertebral artery spasm during direct angiography].
    Legré J; Watel J; Said D; Dufour M; Lavieille J; Louis R
    Ann Radiol (Paris); 1966; 9(7):647-54. PubMed ID: 4959932
    [No Abstract]   [Full Text] [Related]  

  • 25. [Double blind test of hydergine in the aged].
    Bargheon J
    Nouv Presse Med; 1973 Sep; 2(31):2053-5. PubMed ID: 4199834
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of the administration of the drug association: hydergine-thioridazine (HM 51), in the treatment of coronary angina].
    Martelli A; Melilla GN
    G Clin Med; 1968 Mar; 49(3):310-43. PubMed ID: 4985903
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment by hydergine of vertebral artery spasm during angiography by direct route].
    Legre J; Watel J; Said D; Dufour M; Lavieille J; Louis R
    J Belge Radiol; 1967; 50(3):192-5. PubMed ID: 4973170
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hydergine and disorders of cardiac rhythm induced by K-strophanthin].
    Eben-Moussi E; Allain P; Van den Driessche J
    Therapie; 1966; 21(2):375-8. PubMed ID: 4956839
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic findings in 23 geriatric cases treated with hydergine (clinical note)].
    Tessler D
    Hospital (Rio J); 1970 Jul; 78(1):267-70. PubMed ID: 4991827
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hydergine in the symptomatic treatment of cerebrovascular insufficiency. Comparative clinical test with a placebo].
    Teixeira JE
    Hospital (Rio J); 1970 Jun; 77(6):1907-31. PubMed ID: 4992010
    [No Abstract]   [Full Text] [Related]  

  • 31. [Clinical test using Brinaldix plus Hydergine].
    Elizalde JE
    Hospital (Rio J); 1967 Dec; 72(6):1941-2. PubMed ID: 4983683
    [No Abstract]   [Full Text] [Related]  

  • 32. [Use of hydergine in acute ischemic pathology of the brain].
    Gomensoro JB
    Acta Neurol Latinoam; 1967; 13(1):273-82. PubMed ID: 4976823
    [No Abstract]   [Full Text] [Related]  

  • 33. Treatment of aged psychotic patients with hydergine.
    Freeman H; Murray P
    Gerontol Clin (Basel); 1966; 8(5):279-84. PubMed ID: 4960136
    [No Abstract]   [Full Text] [Related]  

  • 34. [Changes of the cerebral circulation time influenced by hydergine].
    Herzfeld U; Wittgen M
    Arztl Forsch; 1971 Jul; 25(7):224-30. PubMed ID: 4998670
    [No Abstract]   [Full Text] [Related]  

  • 35. An ergot alkaloid preparation (hydergine) in geriatric therapy.
    Roubicek J; Geiger C; Abt K
    J Am Geriatr Soc; 1972 May; 20(5):222-9. PubMed ID: 4623679
    [No Abstract]   [Full Text] [Related]  

  • 36. [Hydergine in high doses in neurosurgery for the prevention of postoperative hemorrhagic complications].
    Torelli L; Zotti G
    Friuli Med; 1966; 21(3):379-89. PubMed ID: 4964695
    [No Abstract]   [Full Text] [Related]  

  • 37. [Electroencephalographic findings in the course of cerebrovascular diseases in aged subjects and their changes under the influence of sympathicolytic therapy (hydergine)].
    Kauchtschischwili GM; Pontiggia M; Zerbi F
    G Gerontol; 1966 Dec; 14(12):1221-5. PubMed ID: 4966653
    [No Abstract]   [Full Text] [Related]  

  • 38. [Sympatholytic vasodilator in cerebral circulation disorders].
    Lipke PR
    Hospital (Rio J); 1969 Dec; 76(6):2159-65. PubMed ID: 4984915
    [No Abstract]   [Full Text] [Related]  

  • 39. [Can a hydergine therapy lead to damage of the coronary vessels?].
    Müller FU
    Dtsch Med Wochenschr; 2002 Jun; 127(25-26):1401. PubMed ID: 12134783
    [No Abstract]   [Full Text] [Related]  

  • 40. An ergot alkaloid preparation (Hydergine) in the treatment of presenile brain atrophy (Alzheimer's disease): case report.
    Burian E
    J Am Geriatr Soc; 1974 Mar; 22(3):126-8. PubMed ID: 4204771
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.